The prognostic value of histologic subtypes in primary extremity liposarcoma
- PMID: 2776110
- DOI: 10.1002/1097-0142(19891001)64:7<1514::aid-cncr2820640726>3.0.co;2-2
The prognostic value of histologic subtypes in primary extremity liposarcoma
Abstract
Patients with a localized primary liposarcoma of the extremity who were treated in Memorial Sloan-Kettering Cancer Center between 1968 and 1978 were studied. The prognosis of patients with extremity liposarcoma was analyzed according to histopathologic subtypes. A system of five subtypes was used; well-differentiated, myxoid, fibroblastic, lipoblastic, and pleomorphic liposarcomas. The 5-year treatment failure rates and survival rates were, respectively, 30% and 100% for well-differentiated, 25% and 88% for myxoid, 60% and 58% for fibroblastic, 100% and 40% for lipoblastic, and 64% and 56% for pleomorphic liposarcomas. Although local recurrence was present in all five subtypes, a significant increment in local failure was seen in patients with high-grade liposarcomas. Distant metastasis after the initial operation was not found in patients with well-differentiated liposarcoma and rare in the patients with myxoid liposarcoma. In contrast, 50% of the patients with fibroblastic, lipoblastic, and pleomorphic liposarcoma had a distant relapse within 5 years.
Similar articles
-
Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up.Cancer. 1999 Jan 1;85(1):85-92. doi: 10.1002/(sici)1097-0142(19990101)85:1<85::aid-cncr12>3.0.co;2-a. Cancer. 1999. PMID: 9921978
-
Atypical and malignant neoplasms showing lipomatous differentiation. A study of 111 cases.Am J Surg Pathol. 1987 Mar;11(3):161-83. doi: 10.1097/00000478-198703000-00001. Am J Surg Pathol. 1987. PMID: 3826477
-
Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution.J Orthop Sci. 2018 Nov;23(6):1038-1044. doi: 10.1016/j.jos.2018.06.008. Epub 2018 Jul 11. J Orthop Sci. 2018. PMID: 30007495
-
Dedifferentiated liposarcoma.Semin Diagn Pathol. 2001 Nov;18(4):263-6. Semin Diagn Pathol. 2001. PMID: 11757866 Review.
-
A clinicopathologic comparison of malignant fibrous histiocytoma and liposarcoma.Instr Course Lect. 1989;38:407-17. Instr Course Lect. 1989. PMID: 2539413 Review.
Cited by
-
Liposarcoma of the Parapharyngeal Space: a Rare Entity.Indian J Surg Oncol. 2021 Apr;12(Suppl 1):205-209. doi: 10.1007/s13193-021-01293-w. Epub 2021 Feb 27. Indian J Surg Oncol. 2021. PMID: 33994749 Free PMC article. No abstract available.
-
Management of myxoid liposarcoma of the extremity.Oncol Lett. 2021 Aug;22(2):596. doi: 10.3892/ol.2021.12857. Epub 2021 Jun 9. Oncol Lett. 2021. PMID: 34188698 Free PMC article. Review.
-
Radiotherapy, volume reduction, and short-term surgical outcomes in the treatment of large myxoid liposarcomas.Radiat Oncol J. 2022 Sep;40(3):172-179. doi: 10.3857/roj.2022.00094. Epub 2022 Sep 6. Radiat Oncol J. 2022. PMID: 36065469 Free PMC article.
-
Retroperitoneal and scrotal giant liposarcoma: report of a case.Surg Today. 1998;28(3):339-42. doi: 10.1007/s005950050136. Surg Today. 1998. PMID: 9548324
-
Prognostic factors of metastatic myxoid liposarcoma.BMC Cancer. 2020 Sep 14;20(1):883. doi: 10.1186/s12885-020-07384-1. BMC Cancer. 2020. PMID: 32928160 Free PMC article.